| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5721160 | L'Encéphale | 2017 | 7 Pages |
Abstract
In total, the current data suggest efficiency and good tolerance of the use of PDE-5Â inhibitors in schizophrenic patients with erectile dysfunction. However, further studies focusing on PDE-5Â inhibitors are needed to more deeply assess their efficacy and safety in patients with schizophrenia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
L. Bacconi, F. Gressier,